CAMBRIDGE, Mass.--(BUSINESS WIRE)--PatientsLikeMe is working with Walgreens to help make it easier for people to understand how the medications they take may affect them. Now, anyone researching a ...

WASHINGTON D.C., June 15, 2015—PatientsLikeMe and the U.S. Food and Drug Administration (FDA) have signed a research collaboration agreement to determine how patient-reported data can give new ...

PatientsLikeMe Inc. reports it has acquired pain management web site operator ReliefInsite.com LLC, according to a <a href="http://blog.patientslikeme.com/2010/02/16 ...

PatientsLikeMe, the world’s largest integrated community, health management, and real-world data platform, today announced it has raised $26 million in financing led by Alta Partners, Hambrecht Ducera ...

Patients living with fibromyalgia, PTSD, major depressive disorder are the least satisfied with their care, those with ALS, MS, Parkinson’s are among the most satisfied; a new checklist helps patients ...

UCB announced a partnership with PatientsLikeMe.com to launch an epilepsy-focused patient community, and will report adverse events to the FDA through round-the-clock surveillance. The Belgium and ...

Online network PatientsLikeMe, which offers information and support for people living with a chronic condition, is expanding the amount of patient-generated information it offers through Walgreens.com ...

CAMBRIDGE, MA--(Marketwire - Jan 9, 2013) - PatientsLikeMe and the AKU Society are working together to create the first open, global registry for patients with alkaptonuria (AKU), one of the world's ...

CAMBRIDGE, MA-June 9, 2011-Today, PatientsLikeMe announces the launch of a new feature that helps patients find clinical trials that are right for them and helps companies find patients who are right ...

http://www.youtube.com/watch?v=cfUTG7YnijE If consumers knew the impact their health data could have on advancing scientific research, would they be willing to donate ...

CAMBRIDGE, MA--(Marketwire -08/13/12)- PatientsLikeMe announces it has entered into a collaboration with Merck, known as MSD outside the United States and Canada, to evaluate the impact of psoriasis ...